Back to Trades
Grant4
ROCKET PHARMACEUTICALS, INC.
RCKT
Total Value
$1.7M
Company Information
- Company Name
- ROCKET PHARMACEUTICALS, INC.
- Ticker Symbol
- RCKT
- CIK
- 0001281895
Insider Information
- Role
- Insider
- Location
- CRANBURY, NJ
Filing Details
- Filing Date
- Aug 6, 2025
- Transaction Date
- Aug 4, 2025
- Accession Number
- 0001140361-25-029144
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Aug 4, 2025 | Common Stock | 407,166 | — | Grant/Award | — |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Aug 4, 2025 | Derivative | 554,071 | $3.07 | Grant/Award | $1.7M |
Footnotes
- (F1)Holdings are Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on August 4, 2026, with the remaining shares vesting in equal quarterly installments over the following two years.
- (F2)This option represents a right to purchase a total of 554,071 shares of the Issuer's common stock, one-third of which will become fully vested and exercisable on August 4, 2026, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.